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Abstract 
 
Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year survival 
is one of the indicators used for evaluation of the quality of care after surgery. In this study, we used several 
survival models to determine risk factors, survival times and life expectancies of different types of surgery.  
 
Methods: This study was performed on 310 patients who underwent surgery during a ten years period. Logistic 
regression and Cox regression models were used to analyze the factors leading to death. The Kaplan-Meier 
method (non-parametric) was used to estimate the survival rate. The log-rank test was used to compare survival 
in different groups. To compare life expectancy of different types of surgery, we used the actuarial life table 
method.  
 
Results: Logistic regression showed that stage, grade, age and history of benign malignancy had significant 
relationship with death. Log-rank test showed that there was a significant difference between survival for patients 
with different stages, age and history of benign tumors. Cox regression model demonstrated that the variables of 
stage, grade, age and benign problems were the major risk factors. Actuarial life table model showed that the life 
expectancy for all patients was 10.03 years. This life expectancy in early stages of breast cancer for mastectomy 
and lumpectomy were 8.99 and 8.35 years, respectively, which was not significant. 
 
Conclusion: It can be concluded that the higher stage, grade, age and history of benign tumor were, the most 
important risk factors were correlated to mortality in breast cancer patients. This study showed that there was no 
significant difference between life expectancies of mastectomy and lumpectomy surgery. 
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Introduction 
 
Cancer is the second leading cause of death in devel-
oped countries (12.6%) and it is a public health prob-
lem worldwide. In developed countries, prostate, 
breast and colon cancers are more common ones.1 In 
Iran, it is the third cause of deaths after cardiovascular 
diseases and accidents.2 If this trend continues, by the 
year 2020, the world will be encountered with 15 mil-
lion new cases, two thirds of which will be in the 
newly industrialized and developing countries..3  
Breast cancer is the most prevalent malignancy 
among women and its prevalence was reported 21%. 
It is one of the slow growing types of cancers. Recent 
researches showed that its incidence rate is increasing 
and the age of the onset is decreased. Some known 
risk factors include stage, grade, family history, age at 
diagnosis, menopause status, monarch age and posi-
tive history of benign tumors.3  
In Iran, this cancer is the most lethal one among 
women. The prevalence of breast cancer was reported 
25.4% and deaths due to breast cancer were 12.3%.2,4 
In southern Iran, it was at the top of 10 prevalent can-
cers in the area with a crude rate of 11.58 and age 
specific incidence rate of 18.06.5  
In southern Iran, it was demonstrated that the ma-
jority of patients were diagnosed with an advanced 
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tumor size. Five-year overall survival was 58%. 
There was a significant correlation between survival 
of breast cancer patients and family income, smoking, 
metastases to bone and lung, tumor size and grade, 
lymph node ratio, and number of involved nodes.6 
In this study, we applied several survival models 
to determine risk factors, survival length and life ex-
pectancies of different types of surgery.  
 
 
Materials and Methods 
 
From 1994 to 2003, the information of breast cancer 
patients in Shiraz, southern Iran were collected from 
Hospital-based Cancer Registry of Nemazee Hospital 
affiliated to Shiraz University of Medical Sciences. 
After diagnosis, all patients had undergone either 
mastectomy or lumpectomy and followed during a 
ten-year period. Information on stage, grade, age at 
diagnosis, history of benign tumors and type of sur-
gery were provided. These factors were categorized 
respectively as early, locally advanced and advanced 
for their stages; I, II and III for their grade; less than 
48 and more than 48 years (menarch age)7; and pres-
ence or absence of a benign tumor history.8  
Patients in the early stage underwent either lum-
pectomy or mastectomy but in other stages only mas-
tectomy was done. Regardless of the tumor grade, 
they had undergone either mastectomy or lumpec-
tomy. Survival was considered as the time period be-
tween diagnosis and death (or last visit) of patient. 
Standard statistical methods could not be used for 
longitudinal and censored data, because these data 
were usually skewed and survival lengths were cen-
sored due to immigration, treatment, etc. For analyz-
ing of data, Kaplan-Meire and Log-rank tests were 
used to compare the survival lengths in different 
groups.9,10 Logistic and Cox regression models were 
used to find odds ratio and proportional hazards of the 
affecting factors leading to death.11,12  
Finally, actuarial life table method was applied to 
compare life expectancies for different types of  
surgeries.13,14 For actuarial life table, the distribution 
of N patients based on their status in each follow up 
interval was shown in Table 1. According to the actu-
arial life table method[11], the probability of death in 
the interval [x, x+1) is: 
2
x
x
x
x
Dq WN
=
-
. 
This method supposes that the withdrawal patients 
were observed for half of the period, so the term 
2
x
x
WN - , shows the number of patients at risk. The 
probability of survival in the corresponding interval 
is: Px= 1-qx 
The probability of being alive till x=j for patients 
who were alive at x=i was: 
i
j
ij l
l
P =ˆ .  They were used 
to compute 1, 3, 5 and 10-year survival rates. Other 
life table columns can be computed using qx values. 
For the last group, the value of life expectancy was 
computed by.13 
t
t
t q
qe -+= 1
2
1ˆ , when tqˆ  is the last nonzero qx. 
 
 
Results 
 
Tables 2-5 show the distribution of patients’ status 
based on their stage, grade, age at diagnosis and the 
history of benign tumors. These results showed that 
the survival status of patients was correlated to stage, 
grade, age and history of benign tumors. Also, Tables 
6 and 7 showed the odds ratio and proportional haz-
ard of death for this disease based on logistic regres-
sion model and cox regression model. These models 
showed that the chance of death increased in locally 
advanced and advanced stages, grade ΙΙΙ, age more 
than 48 years and positive history of benign tumors. 
The results were almost the same for both logistics 
and Cox models.  
Table 1: The Distribution of patients according to their status in the follow up 
interval [ x , x+1) 
Status Total Observed in all period Withdrawal 
Total 
xN  xm  xn  
Survived 
x xS W+  xS  xW  
Death 
xD  xd  xd ¢  
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Table 2: Distribution of Patients' Status by to their Stage 
         Stage 
Status  
Early 
No. (%) 
Locally Advanced 
No. (%) 
Advanced 
No. (%) 
Total 
No. (%) 
Alive 151 (79) 37 (19)   3 (2) 191 (100) 
Death   22 (39) 25 (45)   9 (16)   56 (100) 
Total 173 (70) 62 (25) 12 (5) 247 (100) 
2 3 9 .5
.0 0 1p
c =
<
 
 
 
Table 3: Distribution of Patients' Status by to their Grade 
            Grade 
Status 
І 
No. (%) 
ΙΙ 
No. (%) 
ΙΙΙ 
No. (%) 
Total 
No. (%) 
Alive 66 (35)   92 (48) 32 (17) 190 (100) 
Death 11 (20)   31 (55) 14 (25)   56 (100) 
Total 77 (31) 123 (50) 46 (19) 246 (100) 
2 5 .1 4
.0 8p
c =
=
, 
 
 
Table 4: Distribution of Patients' Status by to their Age at diagnosis 
           Age 
Status 
< 48 
No. (%) 
>48 
No. (%) 
Total 
No. (%) 
Alive 162 (64)   92 (36) 254 (100) 
Death   16 (28)   40 (72)   56 (100) 
Total 132 (42) 178(58) 310 (100) 
2 2 3 .3
. 0 0 1p
c =
= <
 
 
 
Table 5: Distribution of Patients' Status by their Benign Tumor History 
Benign Tumor History 
Status 
Positive 
No.   (%) 
Negative 
No,   (%) 
Total 
No,   (%) 
Alive   68 (32) 141 (68) 209 (100) 
Death   36 (66)   18 (34)   54 (100) 
Total 104 (39) 159 (61) 263 (100) 
2 2 0 .9
.0 0 1p
c =
= <
 
 
 
Table 6: Odds Ratio of Death for Breast Cancer Patients According to their Risk Factors (Logistic 
Regression) 
Variable Levels OR 95% C.I. P 
Stage Early 
Locally Advanced 
Advanced 
  1 
  4.64 
20.59 
 
(2.35, 9.12) 
(5.17, 81.9) 
 
<0.001 
<0.001 
Grade І 
ΙΙ 
ΙΙΙ 
  1 
  2.02 
  2.62 
 
(0.94, 4.3) 
(1.07, 6.43) 
 
  0.07 
  0.03 
Age at Diagnosis <48 
>48 
  1 
  4.4 
 
(2.3, 8.3) 
 
<0.001 
History of Benign 
Tumors 
No 
Yes 
  1 
  4.15 
 
(2.2, 7.8) 
 
<0.001 
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The Kaplan-Meier curves showed that there were 
significant differences between the patients' survival 
curves. Patients in early stage, grade І, age less than 
48 and without a history of benign tumors experi-
enced higher survival curves (Figure 1). Table 8 
shows the results of the Log-Rank test for these vari-
ables. These results were confirmed by Kaplan- 
Meier Curves in Figure 1. 
Table 7: Proportional risk of death for breast cancer according to their risk factors (Cox Regression) 
Variable Levels PH 95% C.I. P 
Stage Early 
Locally Advanced 
Advanced 
1 
4.17 
4.83 
- 
(2.35, 7.41) 
(2.21, 8.55) 
 
<0.001 
<0.001 
Grade I 
II 
III 
1 
2.005 
2.055 
- 
(1.01, 3.99) 
(0.93, 4.5) 
  - 
  0.048 
  0.074 
Age at Diagnosis <48 
>48 
1 
3.39 
 
(1.89, 6.56) 
 
<0.001 
History of Benign Tumors No 
Yes 
1 
2.94 
 
(1.67, 5.19) 
 
<0.001 
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Figure 1: Kaplan- Meier survival curves for some important variables.  
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By applying the actuarial life table technique, 1, 3, 5 
and 10-year survival rates for these patients were 97%, 
82%, 70% and 53%, respectively. The life expectancies 
resulted from actuarial life table for early stage in differ-
ent types of surgeries are shown in Table 9. The differ-
ence between these two life expectancies (8.99 and 
8.35) was not statistically significant (p=0.0602). 
Table 10 shows survival rates in different stages. 
This table contains 5 year survival for Carolina state 
(1997) for comparison purpose.15 It is obvious that 
10-year survival rate for early stage patients were 
higher than other groups. 
Discussion 
 
Breast cancer is a non-contiguous disease whose risk 
factors were investigated in recent decades. Some risk 
factors are controllable, and some such as sex and 
family history are not. In this study, mean and median 
age for breast cancer patients in Shiraz was 47.06 and 
46, respectively. The results showed that stage was a 
very important risk factor. Early stage patients had a 
higher survival curve and experienced higher survival 
rates. The chance of death for locally advanced and 
advanced stage patients was 4.64 and 20.59 times more 
Table 8: Median Survival Time and Log-Rank test for Breast Cancer Patients According to their Risk Factors 
Variable Levels Median Survival Time 2
Log Rankc -  
P 
Stage Early 
Locally Advanced 
Advanced 
64 
60 
60 
 
  9.15 
 
  0.01 
Grade І 
ΙΙ 
ΙΙΙ 
68 
60 
61 
 
  0.11 
 
  0.70 
Age at Diagnosis <48 
>48 
45 
64 
 
21.19 
 
<0.001 
History of Benign Tumors No 
Yes 
65 
60 
 
  4.84 
 
  0.04 
 
Table 9: Actuarial life table for early stage of breast cancer by the two types of surgery. 
Mastectomy Lumpectomy Interl 
(x , x +1) qx lx e qx lx e 
0-1 
1-2 
2-3 
3-4 
5-6 
6-7 
6-7 
7-8 
8-9 
9t 
0.009 
0.059 
0.036 
0.059 
0.0 
0.0 
0.28 
0.0 
0.0 
- 
100000 
  99100 
  90181 
  86935 
  81806 
  81806 
  81806 
  58900 
  58900 
  58900 
8.99 
8.07 
7.82 
7.15 
6.51 
5.51 
4.51 
5.07 
4.07 
3.07 
0.0 
0.092 
0.033 
0.093 
0.0 
0.0 
0.330 
0.0 
0.0 
- 
100000 
100000 
  90800 
  87804 
  79638 
  79638 
  79638 
  53358 
  53358 
  53358 
8.35 
7.35 
7.05 
6.28 
5.87 
4.87 
3.87 
4.53 
4.53 
2.53 
 
07.3
28.0
25.01
2
1ˆ =-+=te  53.233.0
33.01
2
1ˆ =-+=te  
 
 
Table 10: 10-Year Survival Rates (%) for Breast Cancer Patients According to their Stage 
Year Survival Rates Early Locally Advanced Advanced 
1-Year 99 98 88 
3-Year 85 80 55 
* 5-Year 79 62 30 
10-Year 54 53 19 
* 5- Year  (Carolina 1997) 94 79 53 
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than that in the early stage. Adnan Ezzat and Madras 
Raja16 in a survey in Saudi Arabia in 1997 found that 
there was a significant difference among patients’ sur-
vival curves according to their stages and early stage 
patients experience a higher survival curve than the 
other stage patients. This result has been confirmed in 
another research in Taiwan by Wei Shuwang et al.17 
Furthermore, Simsek8 (2000) in Carolina showed that 
this factor had a significant effect on death.  
Grade is another important risk factor; the risk of 
death for patients with grade ΙΙ and ΙΙΙ were 2.02 and 
2.62 times more than the risk for patients with grade 
І. These results showed that patients with grade І ex-
perienced a higher survival curve.  
Age at diagnosis is an important risk factor. This fac-
tor plays a crucial role in patients' career. We catego-
rized patients based on monarch age to less and more 
than 48 years as described by Ayatollahi et al. (2003)7 
for monarch age in Shiraz to be 48 years). Patients 
older than 48 years had a lower survival curve and the 
chance of death was 4.4 times more than patients 
younger than 48 years old. Ezzat et al.16 in a survey in 
Saudi Arabia in 1997 categorized ages of patients to 
less than 40, 41-60 and more than 60 years, and found 
that there was a significant difference among patients' 
survival curve according to their age groups. Simsek8 
(2000) in Carolina showed that the probability of 
death for patients aged more than 65 years was 1.26 
times as much as that for other patients. 
Kaplan-Meier curve and Log-Rank test showed 
that patients with positive history of benign tumors 
had a lower survival curve than the patients without 
the history, and the chance of death for these patients 
was 4.15 times as much as that for the patients with-
out benign tumor history. 
Our results showed that stage, grade, age at diag-
nosis and positive history of benign tumors were cru-
cial risk factors and could increase the chance of 
death. It is concluded that if the disease is diagnosed 
in the primary stage and grade, it will be controllable 
and increase the patients’ survival time. 
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